Author: CSN
Trump may finally reschedule pot, and cannabis insiders have concerns
Another concern: Trump’s supposed interest in rescheduling cannabis comes right when lawmakers at both the federal and state levels are…
Cannabis stocks surge as White House weighs marijuana reclassification
Cannabis stocks jumped Friday as reports emerged that the White House is preparing to ease federal restrictions on marijuana. Some…
Review of Medical Cannabis Use Finds Little Evidence of Benefit
Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science actually…
Tilray’s stock takes off on hope that cannabis will soon be treated more like steroids than heroin
Tilray’s stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to…
Tilray’s stock takes off on hope that cannabis will soon be seen as more like steroids than heroin
Trump is reportedly mulling an executive order to downgrade marijuana to a Schedule III drug, which could open the door…
Cannabis rescheduling fuels talk of an insurance boom
Tilray Brands and Canopy Growth jumped more than 40 per cent in New York trading. A specialist fund, the Amplify…
Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change
Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance.
Cannabis stocks spike on reports Trump plans to ease federal pot restrictions
The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.
Why Canopy Growth Stock Popped Today
Canopy Growth (NASDAQ: CGC) stock soared 17% through 12:50 p.m. ET Friday on some positive marijuana news out of the…
Cannabis stocks surge. Trump may reclassify marijuana—but White House says a final decision hasn’t been made.
The reclassification of the drug would reduce the tax burden on the companies.
Recent Comments